Antipodes Partners LTD Merck & Co., Inc. Transaction History
Antipodes Partners LTD
- $2.85 Billion
- Q4 2024
A detailed history of Antipodes Partners LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 1,848,631 shares of MRK stock, worth $165 Million. This represents 6.46% of its overall portfolio holdings.
Number of Shares
1,848,631
Previous 1,575,816
17.31%
Holding current value
$165 Million
Previous $179 Million
2.77%
% of portfolio
6.46%
Previous 6.33%
Shares
24 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.23 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.48 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...